Outset Medical
Cash Flow
Last updated:
Cash flow statement presents a set of outflows and inflows of cash within a company through operating, investing and financing activities. Over the last year, operating activities of Outset Medical generated cash of -$131,373,000, which is more than the previous year. Cash used in financing activities reached the amount of $43,652,000 last year. Net change in cash is therefore -$4,695,000.
Cash Flow
| 2018 | -46.44M | -68.77M | 134.87M |
|---|---|---|---|
| 2019 | -70.29M | 74.29M | 249K |
| 2020 | -99.01M | 3.94M | 385.68M |
| 2021 | -130.26M | -142.50M | 160.14M |
| 2022 | -145.72M | -66.29M | 72.89M |
| 2023 | -131.37M | 83.02M | 43.65M |
OM Cash Flow Statement (2018 – 2023)
| 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | |
|---|---|---|---|---|---|---|
Cash at beginning of period | 76.53M | 215.65M | 328.28M | 37.66M | 33.41M | 13.76M |
Operating activities | ||||||
Net income | -172.79M | -162.95M | -131.93M | -121.49M | -68.29M | -49.78M |
| Adjustments to reconcile net income to cash generated by operating activities: | ||||||
Depreciation and amortization | 5.81M | 5.16M | 5.16M | 3.15M | 1.93M | 1.06M |
Stock-based compensation expense | 38.63M | 27.20M | 17.44M | 21.43M | 883K | 0 |
| Deferred income tax benefit | 38.63M | 27.20M | 17.44M | 21.43M | 883K | 0 |
| Changes in operating assets and liabilities: | ||||||
Accounts receivable, net | -5.09M | -2.50M | -19.13M | -2.56M | -2.88M | -552K |
Inventories | 1.64M | -14.73M | -22.04M | -16.28M | -5.02M | -2.21M |
Accounts payable | 5.31M | -1.28M | -3.06M | 737K | 802K | 2.67M |
Cash generated by operating activities | -131.37M | -145.72M | -130.26M | -99.01M | -70.29M | -46.44M |
Investing activities | ||||||
Purchases Of Investments | -172.28M | -261.15M | -178.43M | -32.88M | -91.87M | -132.31M |
Investments In Property Plant And Equipment | -3.44M | -8.32M | -3.10M | -9.10M | -3.29M | -1.76M |
Acquisitions Net | 0 | 57.97M | 139.39M | 31K | -77.59M | 0 |
Cash generated by investing activities | 83.02M | -66.29M | -142.50M | 3.94M | 74.29M | -68.77M |
Financing activities | ||||||
Common Stock Issued | 10.42M | 8.04M | 149.08M | 254.80M | 258K | 134.56M |
Payments for dividends | 0 | 0 | 0 | 0 | 0 | 0 |
Repurchases of common stock | 0 | 0 | 0 | 0 | 0 | 0 |
Repayments of term debt | 33.22M | 64.85M | 0 | -30.99M | -9K | -9K |
Cash used in financing activities | 43.65M | 72.89M | 160.14M | 385.68M | 249K | 134.87M |
Net Change In Cash | -4.69M | -139.12M | -112.62M | 290.61M | 4.25M | 19.65M |
Cash at end of period | 71.83M | 76.53M | 215.65M | 328.28M | 37.66M | 33.41M |
| Data source | Data source | Data source | Data source |